18F-FDG PET is Superior to WHO Grading as a Prognostic Tool in Neuroendocrine Neoplasms and Useful in Guiding PRRT: A Prospective 10-Year Follow-up Study-Reference-Cited by-同舟云学术

18F-FDG PET is Superior to WHO Grading as a Prognostic Tool in Neuroendocrine Neoplasms and Useful in Guiding PRRT: A Prospective 10-Year Follow-up Study

Published:2020-10-16 Issue:6 Volume:62 Page:808-815
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Binderup Tina,Knigge Ulrich,Johnbeck Camilla Bardram,Loft Annika,Berthelsen Anne Kiil,Oturai Peter,Mortensen Jann,Federspiel Birgitte,Langer Seppo W.,Kjaer Andreas

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference37 articles.

1. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

2. Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

3. Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors

4. Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

5. An International Ki67 Reproducibility Study

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Theranostics in Neuroendocrine Tumors: Updates and Emerging Technologies;Current Problems in Cancer;2024-10

2. European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well‐differentiated small intestine neuroendocrine tumours;Journal of Neuroendocrinology;2024-07-08

3. Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers;Journal of Clinical Medicine;2024-06-02

4. Theranostics in Neuroendocrine Tumors;The Cancer Journal;2024-05

5. Evaluación de la heterogeneidad molecular en tumores neuroendocrinos mediante PET/TC con [68Ga]Ga-DOTA-TOC y [18F]FDG;Revista Española de Medicina Nuclear e Imagen Molecular;2024-05